ReviewPharmacoEconomics2018

Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.

Nasuh C Büyükkaramikli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.